| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $110K | -33.8% |
| R&D Expense | $691K | -35.7% |
| SG&A Expense | $2.5M | -14.8% |
| Operating Income | -$3.6M | +21.3% |
| Net Income | -$3.6M | +17.9% |
| EPS (Basic) | -$1.03 | +40.5% |
| EPS (Diluted) | -$1.03 | +40.5% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.3M | +12.7% |
| Accounts Receivable | $6K | -78.9% |
| Current Assets | $2.4M | -6.6% |
| Total Assets | $3.1M | -6.5% |
| Current Liabilities | $359K | -55.1% |
| Stockholders' Equity | $2.7M | +8.9% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.5M | +12.7% |
| Capital Expenditures | $1K | +0.0% |
| Investing Cash Flow | -$378K | -0.6% |
| Financing Cash Flow | $3.1M | — |
| Free Cash Flow | -$2.5M | +12.7% |